| LDR | 01201namZa22002771iZ4500 | ||
| 001 | 100717298 | ||
| 003 | MiAaHDL | ||
| 005 | 20150625000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 810109s1969####dcu######b###f001#0#eng#d | ||
| 035 | ⊔ | ⊔ | ‡asdr-umn9925029930001701 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)9523306 |
| 035 | ⊔ | ⊔ | ‡a(MnU)notisABR8217 |
| 035 | ⊔ | ⊔ | ‡z(MnU)Aleph002034017 |
| 040 | ⊔ | ⊔ | ‡aMNU-B ‡cMNU-B |
| 100 | 1 | ⊔ | ‡aUsdin, Earl. |
| 245 | 1 | 0 | ‡aSupplement no. 1 (addenda and errata) to Psychotropic drugs and related compounds / ‡cEarl Usdin and Daniel H. Efron. |
| 260 | ⊔ | ⊔ | ‡aWashington : ‡bU.S. Dept. of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration, National Institute of Mental Health, Pharmacology Section, Psychopharmacology Research Branch, ‡c1969. |
| 300 | ⊔ | ⊔ | ‡a148 pages ; ‡c24 cm. |
| 336 | ⊔ | ⊔ | ‡atext ‡btxt ‡2rdacontent |
| 337 | ⊔ | ⊔ | ‡aunmediated ‡bn ‡2rdamedia |
| 338 | ⊔ | ⊔ | ‡avolume ‡bnc ‡2rdacarrier |
| 490 | 0 | ⊔ | ‡aPublic Health Service publication; ‡vno. 1589-A |
| 504 | ⊔ | ⊔ | ‡aIncludes bibliographies. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aPsychopharmacology. |
| 700 | 1 | ⊔ | ‡aEfron, Daniel H. |
| 740 | 0 | ⊔ | ‡aPsychotropic drugs and related compounds : supplement no. 1 (addenda and errata). |
| CID | ⊔ | ⊔ | ‡a100717298 |
| DAT | 0 | ⊔ | ‡a20150325204506.0 ‡b20150625000000.0 |
| DAT | 1 | ⊔ | ‡a20150625143710.0 ‡b2024-03-12T17:56:49Z |
| CAT | ⊔ | ⊔ | ‡aSDR-UMN ‡dEX LIBRIS - ALMA ‡lloader.pl-003-020 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-umn9925029930001701 ‡aumn ‡bSDR ‡cUMN ‡pumn.319510001619821 ‡sUMN ‡19925029930001701 |
| 974 | ⊔ | ⊔ | ‡bUMN ‡cUMN ‡d20240312 ‡sgoogle ‡uumn.319510001619821 ‡y1969 ‡rpd ‡qbib ‡tUS fed doc |